Scientists modify chickens to lay cancer-fighting eggs

Scientists modify chickens to lay cancer-fighting eggs
Image: Biswarup Ganguly
  • The eggs contain an antiviral protein called human interferon beta.
  • This protein is known to combat some forms of cancer and other conditions.
  • The unusual technique could one day provide cheaper and more effective treatments.

Scientists in Japan have genetically modified chickens to lay eggs containing an extremely valuable protein that helps treat cancer, hepatitis and multiple sclerosis in humans.

The cost of one of these so-called 'golden eggs' is estimated to be between $535,995 and $2.6 million. However, researchers described their work as still being in the early steps and on the road toward cheaper cancer treatment.

"This is a result that we hope leads to the development of cheap drugs," Hironobu Hojo, professor at Osaka University, told The Japan News. "In the future, it will be necessary to closely examine the characteristics of the agents contained in the eggs and determine their safety as pharmaceutical products."

The researchers, working out of Japan's Biomedical Research Institute at the National Institute of Advanced Industrial Science and Technology, recently described their findings in a paper published in Nature.

The 'golden eggs' contain high amounts of human interferon beta, an antiviral protein thought to combat some forms of cancer and hepatitis, and to slow the progression of multiple sclerosis.

How it works

To get hens to lay the valuable eggs, the team used genome-editing technology to modify cells from cockerel embryos so that the animal's protein-producing DNA would go on to produce human interferon beta in eggs instead of normal egg whites. These cells were then reinserted into the embryos and the cockerels later mated with hens.

After two generations, hens were laying eggs with visibly cloudier whites that contained human interferon beta.

Image: Oishi et al.

The researchers are working with Cosmo Bio, a Japanese reagent maker, to potentially produce the drug for the commercial market.

"For interferon-beta protein, we have about 20 hens in-house," Mika Kitahara, a spokesperson for Cosmo Bio, told The Telegraph. "So far our hens produce the eggs constantly, just like normal hens."

Kitahara noted that the process doesn't seem to harm the chickens. "These hens can produce eggs constantly, so we can obtain recombinant proteins in large amounts and with stability," she said. "In addition, this system doesn't involve killing hens."

A Magnetotail Around Mars Would Cause the Planet to Terraform Itself

Imagine the birth of an entirely new ocean on the Martian surface. 

 

Artist rendition of a terraformed Mars. Flickr.
Technology & Innovation

There are lots of arguments for exploring space and colonizing other planets. Exploration is a natural part of our species. The knowledge we gain is bound to propel our scientific understanding and capabilities. And admittedly, there are plenty of commercial reasons too. Plus, sooner or later, the Earth is going to die out. To survive, we’ll have to become an interplanetary species.

Keep reading Show less

The future of humanity: can we avert disaster?

Climate change and artificial intelligence pose substantial — and possibly existential — problems for humanity to solve. Can we?

Credit: stokkete / 223237936 via Adobe Stock
13-8
  • Just by living our day-to-day lives, we are walking into a disaster.
  • Can humanity wake up to avert disaster?
  • Perhaps COVID was the wake-up call we all needed.
Keep reading Show less

Genetics of unexplained sudden cardiac arrest

New research shines a light on the genetics of sudden cardiac deaths.

Photo: Pixel-Shot / Adobe Stock
Surprising Science
  • Soccer player Christian Eriksen of Denmark recently collapsed on the field from a cardiac arrest. Thankfully, he survived.
  • A new study examined the genetics underlying unexplained sudden cardiac death.
  • About 20 percent of these unexplained deaths are likely due to genetics.
Keep reading Show less
Technology & Innovation

Finally, a scientific cure for the hiccups

A new device cured the hiccups 92 percent of the time in a recent study involving more than 200 participants.

Quantcast